Factor XIII Antibodies

Santa Cruz Biotechnology offers a broad range of Factor XIII Antibodies for research focused on understanding this crucial protein. Factor XIII Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Factor XIII, also known as fibrin-stabilizing factor, plays a vital role in the coagulation cascade by cross-linking fibrin, which stabilizes blood clots and aids in wound healing. Proper functioning of Factor XIII is essential for maintaining hemostasis, and deficiencies can lead to bleeding disorders. Understanding Factor XIII mechanisms is critical for developing therapeutic strategies for coagulation-related diseases. Research into Factor XIII continues to reveal new insights about its role in various physiological processes beyond blood clotting, including tissue repair and immune response. Ongoing studies of Factor XIII contribute to advancing knowledge in cardiovascular medicine and wound healing. Factor XIII research has highlighted significant implications for treating various medical conditions, from surgical complications to autoimmune disorders. Santa Cruz Biotechnology monoclonal antibodies for Factor XIII support researchers worldwide in advancing scientific understanding of blood coagulation and related therapeutic applications.